HIV-1 infection in persons attending sexually transmitted disease (STD) clinics in Minnesota (MN). NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HIV-1 infection in persons attending sexually transmitted disease (STD) clinics in Minnesota (MN).

Int Conf AIDS. 1989 Jun 4-9;5:90 (abstract no. M.A.P.72). Unique Identifier : AIDSLINE ICA5/00022989
Danila R; Henry K; Simpson M; Osterholm M; MacDonald K; MN Dept. of Health, MN, USA

Abstract: OBJECTIVE: To determine HIV-1 seroprevalence and risk factors associated with infection in persons attending STD clinics in Minnesota. METHODS: 1094 patients attending two STD clinics from 4/1/88-11/1/88 were systematically selected; participants were interviewed for HIV-1 infection risks and had blood drawn for HIV-1, syphilis, and hepatitis B serology. RESULTS: Questionnaire and serology data were completed for 932/1094 (85%) participants. HIV-1 infection was associated with male-to-male sex (p less than 0.001), and among homosexual/bisexual males, receptive anal intercourse (p less than 0.05). HIV-1 race-specific rates were: white 1.3% (7/529); black 1.1% (4/352); Hispanic 6.3% (1/16); other 0.0% (0/35). TABULAR DATA, SEE ABSTRACT VOLUME. CONCLUSIONS: In Minnesota, HIV-1 infection in STD patients is primarily limited to those with a history of male-to-male sex or IV drug use. Thus, in low prevalence areas, HIV-1 antibody testing should be targeted to STD patients known to be at highest risk.
Keywords: Adult Bisexuality Female Homosexuality Human HIV Seropositivity *HIV Seroprevalence HIV-1 Male Minnesota/*EPIDEMIOLOGY Sex Behavior Sexually Transmitted Diseases/*EPIDEMIOLOGY Substance Abuse, Intravenous ABSTRACTKWDadultbisexualityfemalehomosexualityhumanhivseropositivityKWDhivseroprevalencehiv-1maleminnesota/KWDepidemiologysexbehaviorsexuallytransmitteddiseases/KWDepidemiologysubstanceabuse,intravenousabstract
900930
M9094762

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .